SUVEN PHARMACEUTICALS
|
The Current P/E Ratio of SUVEN PHARMACEUTICALS is 137.78.
Share Price | ₹901.8 | Sep 22,2025 |
Market Cap | ₹34,501.0 Cr | |
Earnings-TTM | ₹250.4 Cr | TTM-Consolidated Results |
Price/Earnings | 137.78x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SUVEN PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹34,501.0 Cr] as on Sep 22,2025
(/) Earnings [ ₹250.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 137.78x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay 137.78 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUVEN PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SUVEN PHARMACEUTICALS
PE Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 53.26x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 34.8x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 110.23x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 29.26x.
How does SUVEN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SUVEN PHARMACEUTICALS | 250.40 | 137.78 | 34,501.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.89 | 394,451.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 70.13 | 161,727.0 |
CIPLA LTD | 5,406.81 | 23.03 | 124,533.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.77 | 123,673.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.97 | 108,629.0 |
MANKIND PHARMA LTD | 1,905.51 | 56.24 | 107,160.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.47 | 104,190.0 |
LUPIN LTD | 3,722.18 | 24.61 | 91,599.8 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.99 | 64,910.4 |
ABBOTT INDIA LTD | 1,452.29 | 44.20 | 64,191.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUVEN PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.97x |
Max industry PE | 137.78x |
Median industry PE | 37.89x |
Average industry PE | 46.92x |
You may also like the below Video Courses